Advertisement
Advertisement
U.S. markets open in 4 hours 14 minutes
Advertisement
Advertisement
Advertisement
Advertisement

bluebird bio, Inc. (BLUE)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.78+0.20 (+3.04%)
At close: 04:00PM EDT
7.61 +0.83 (+12.24%)
Pre-Market: 05:16AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Head and Shoulders Bottom

Head and Shoulders Bottom

Previous Close6.58
Open6.29
Bid0.00 x 2200
Ask0.00 x 900
Day's Range6.12 - 8.18
52 Week Range2.87 - 17.85
Volume27,261,975
Avg. Volume8,623,811
Market Cap522.886M
Beta (5Y Monthly)1.33
PE Ratio (TTM)N/A
EPS (TTM)-10.43
Earnings DateNov 03, 2022 - Nov 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for BLUE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • bluebird bio, Inc.
    Analyst Report: Vertex Pharmaceuticals, Inc.Vertex Pharmaceuticals develops therapies to address cystic fibrosis and other diseases. The company was founded in 1989 in Cambridge, Massachusetts and has 3,500 employees. It has research programs and facilities in the U.S., the U.K., and Canada. The shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
Advertisement
Advertisement